Financhill
Back

Zevra Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.

Zevra Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 8.82 Buy
20-day SMA: 8.62 Buy
50-day SMA: 8.15 Buy
200-day SMA: 6.34 Buy
8-day EMA: 8.88 Buy
20-day EMA: 8.66 Buy
50-day EMA: 8.18 Buy
200-day EMA: 6.74 Buy

Zevra Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 61.61 Buy
Chaikin Money Flow: 68733 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.17 - 8.91) Buy
Bollinger Bands (100): (6.37 - 8.45) Buy

Zevra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Zevra Therapeutics Stock

Is Zevra Therapeutics Stock a Buy?

ZVRA Technical Analysis vs Fundamental Analysis

Buy
67
Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics a Buy or a Sell?

Zevra Therapeutics Stock Info

Market Cap:
487.32M
Price in USD:
9.13
Share Volume:
458.22K

Zevra Therapeutics 52-Week Range

52-Week High:
9.30
52-Week Low:
4.20
Buy
67
Zevra Therapeutics (ZVRA) is a Buy

Zevra Therapeutics Share Price Forecast

Is Zevra Therapeutics Stock a Buy?

  • Zevra Therapeutics share price is 9.13 while ZVRA 8-day exponential moving average is 8.88, which is a Buy signal.
  • The stock price of ZVRA is 9.13 while Zevra Therapeutics 20-day EMA is 8.66, which makes it a Buy.
  • Zevra Therapeutics 50-day exponential moving average is 8.18 while ZVRA share price is 9.13, making it a Buy technically.
  • ZVRA stock price is 9.13 and Zevra Therapeutics 200-day simple moving average is 6.74, creating a Buy signal.

Fundamental Analysis of Zevra Therapeutics

Is Zevra Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.

Technical Analysis of Zevra Therapeutics

Should I short Zevra Therapeutics stock?

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.